Immuneering Corporation · NASDAQ:IMRX
BlackRock, Inc. reported a 6.70% stake in Immuneering Corporation (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 28, 2026
BlackRock, Inc. reported a 6.70% stake in Immuneering Corporation, 4,356,235 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 4,356,235
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.70% | 4,356,235 |
Source
Related
- Immuneering Corporation
- BlackRock, Inc.
- Immuneering Corporation shareholders
- Form 4 · Zeskind Benjamin J. · Jun 24, 2026
- Form 4 · Hall Brett Matthew · Jun 16, 2026
- Schedule 13G/A · Zeskind Benjamin J. · Jan 22, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jan 15, 2026
- Schedule 13G · Empery Asset Management, LP · Oct 21, 2025